Full-Time

VP of Global Sales

Gator Bio

Gator Bio

51-200 employees

Biomolecular interaction analysis via BLI sensors

Compensation Overview

$250k - $280k/yr

Palo Alto, CA, USA

Hybrid

Hybrid schedule with on-site work in Palo Alto, California; international travel may be required.

Bachelor's

Category
Sales & Account Management (2)
,
Required Skills
Market Research
Sales
Lead Generation
Forecasting
Social Media

Get referred to Gator Bio

See people who can refer or advise you

Requirements
  • Ability to lead global sales and support teams to achieve $50-million and higher annual revenue.
  • 10+ years’ experience as a sales leader with a proven track record of growing the business at double digit growth rate.
  • Hands-on sales experience in life sciences analytical tool space.
  • Understanding of SPR, BLI, and molecular interaction techniques preferred.
  • Knowledge of analytical technologies for antibodies, proteins, small molecules, and CGT.
  • Demonstrated ability to meet sales forecasts and generate healthy revenue stream.
  • Experience in building and improving process and data driven sales system.
  • Leadership skills with outstanding communication, interpersonal, and customer service skills.
  • Planning, organizational, and creative thinking skills.
  • Strategic thinker and entrepreneurial spirit.
  • Working with Marketing and other departments to achieve sales objectives.
  • Experience in leading the FAS and FSE teams.
  • Hands-on with CRM technologies and tools.
  • Degree in scientific and technical fields preferred.
Responsibilities
  • Lead the sales teams in North America, Europe, and Asia Pacific (excluding China) under a single global operating cadence, forecast process, and pricing discipline.
  • Lead the Field Application Scientist (FAS) and Field Service Engineer (FSE) teams, integrating the commercial and technical field functions into one accountable organization.
  • Develop the global sales strategy and translate it into an executable annual and quarterly sales plan, with clear regional targets, quotas, and territory design.
  • Develop, implement, and execute a sales plan to sell capital equipment and consumables to pharma, biopharma, biotech, CRO, CDMO, and academic research customers.
  • Own the global revenue number, with separate visibility into instrument placements and biosensor consumables pull-through.
  • Create accurate sales forecasts and deliver forecast accuracy that withstands investor, auditor, and Board scrutiny.
  • Own and optimize the CRM as the single source of commercial truth, enforcing data hygiene and adoption across every region.
  • Define and enforce the sales process, including qualification criteria, stage definitions, demonstration and evaluation protocols, and close plans.
  • Manage the sales funnel end to end — top-of-funnel volume, stage conversion, cycle time, and win/loss analysis — and act on leading indicators before they become missed quarters.
  • Build a qualified prospect base, with the goal of closing sales to meet revenue targets.
  • Lead, coach, and mentor sales team members to achieve both company and personal goals; motivate the team, track performance, and report metrics.
  • Provide hands-on support to sales representatives, including joint customer visits, deal structuring, obstacle removal, and personally closing strategic opportunities.
  • Build sales enablement capability, including onboarding, product and application training, competitive positioning, objection handling, and pricing guardrails.
  • Develop and manage global distribution channels; determine the direct-versus-distributor mix by region and hold partners accountable to performance.
  • Secure new contracts with customers, manage ongoing contracts, write proposals, and negotiate new deals.
  • Work with Marketing to strengthen the Gator Bio brand, build market awareness, and generate qualified leads; own the definition of a qualified lead and close the loop on lead quality.
  • Promote the company brand by writing articles, posting on social media, and attending conferences and trade shows to generate leads and expand the customer base.
  • Partner with Manufacturing and Supply Chain on demand forecasting, lead times, and instrument and consumable availability to meet market commitments.
  • Partner with Quality on customer complaints, field corrective actions, and product reliability feedback.
  • Partner with Finance on pricing, discount governance, revenue recognition, and commercial reporting.
  • Develop, manage, and control the sales department budget across global markets.
  • Identify market trends and customer needs, and feed structured voice-of-customer input back to Product and R&D.
  • Coordinate efforts and activities with other departments, including Customer Success and Marketing.
  • Communicate regularly with the CEO on progress, difficulties, problems, and solutions.
  • Work with the executive team to grow the company’s value.

Gator Bio provides instruments and reusable biosensors for biomolecular analysis using Biolayer Interferometry (BLI) technology. These tools work by detecting light interference patterns to measure how molecules like proteins and small compounds bind to one another in real time. Unlike many traditional methods, Gator Bio offers a system with reusable probes and integrated technical support to help pharmaceutical and academic researchers study reaction rates and molecular binding sites. The company's goal is to provide precise data that helps scientists accelerate the drug discovery and clinical trial process.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Palo Alto, California

Founded

2017

Get referred to Gator Bio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • HIS XT probes launched Feb. 18, 2026, with immediate availability.
  • Hudson automation integration widened Gator's addressable market among pharma and CROs.
  • Monod partnership targets first-half-2026 biosensor launch, adding royalties and product differentiation.

What critics are saying

  • Sartorius's patent fight against Gator Bio threatens U.S. importation and sales.
  • If Gator loses the 2022 ITC case, GatorPrime and GatorPlus revenue disappears.
  • Monod Bio controls the NovoBody ligand supply, creating partner dependence and launch risk.

What makes Gator Bio unique

  • Feb. 2026 HIS XT probes use Monod Bio's AI-designed NovoBody anti-His binder.
  • Gator Bio's Pivot and Pro systems pair with Hudson automation for 1,200+ samples daily.
  • Gator Bio positions BLI as validation infrastructure for AI protein design workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

401(k) Company Match

Paid Vacation

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-4%

2 year growth

-2%
PR Newswire
Feb 18th, 2026
Gator Bio launches HIS XT Probes with AI-designed NovoBody technology for protein analysis

Gator Bio has launched HIS XT Probes featuring AI-designed NovoBody technology for His-tagged protein analysis. The probes use computationally designed binding proteins to deliver enhanced affinity, baseline stability and data quality for antibody characterisation and biologics research. The company describes these as industry-first probes designed specifically for protein analysis applications. The technology aims to improve performance standards in biologics research and antibody development workflows. Gator Bio is based in Palo Alto, California and Seattle.

PR Newswire
Dec 3rd, 2025
Monod Bio and Gator Bio Partner to Develop Next-Generation Biosensors for Advanced Life Science Research

Monod Bio and Gator Bio partner to develop next-generation biosensors for advanced life science research. News provided by. Gator Bio Gator Bio will integrate one of Monod's AI-designed NovoBody(TM) binding proteins into its industry-leading biolayer interferometry platform. NovoBody(TM) binding proteins deliver superior performance, stability, and engineerability compared to traditional monoclonal antibodies SEATTLE and PALO ALTO, Calif., Dec. 3, 2025 /PRNewswire-PRWeb/ - Monod Bio, a leader in computational protein design, and Gator Bio, a pioneer in biolayer interferometry (BLI) technologies, today announced a partnership to integrate one of Monod's proprietary AI-designed NovoBody(TM) protein binders into Gator's biosensor platform. The collaboration combines Monod's advanced AI-based protein design technology with Gator's proven BLI platform to deliver next-generation biosensing capabilities. Under the terms of the license agreement, Monod will supply NovoBody(TM) binding proteins to Gator Bio for use in a new biosensor product offering, one of the first to incorporate an AI-designed binding molecule. Gator Bio will oversee manufacturing, sales, and marketing of the biosensor, while Monod will receive upfront, supply, and royalty payments. The product launch is anticipated in the first half of 2026. "Our collaboration with Gator Bio marks a significant milestone in the adoption of computationally designed binding proteins for biosensing applications, paving the way for broader use of NovoBody(TM) binding proteins across life science research and diagnostics," said Daniel Silva Manzano, PhD, CEO of Monod Bio. "NovoBody(TM) binding proteins are computationally designed to deliver superior stability, manufacturability, and performance compared to traditional antibodies." "At Gator Bio, we are positioned at the intersection of AI innovation and experimental validation," said Hong Tan, PhD, CEO of Gator Bio. "Our BLI instruments are a critical enabling technology for the AI protein design revolution, providing the real-time, label-free characterization that validates computationally designed molecules. By incorporating AI-designed NovoBody(TM) binding proteins into our biosensor portfolio, we are both advancing and benefiting from the AI transformation of biologics development." "This collaboration exemplifies our 'Monod Inside' business model," said Carl Walkey, PhD, VP of Business Development at Monod Bio. "By integrating NovoBody(TM) binding proteins into leading industry platforms like Gator's, we're enabling partners to rapidly bring breakthrough products to market." About Monod Bio Monod Bio is a Seattle-based biotechnology company and a spinout from the David Baker Lab at the University of Washington's Institute for Protein Design, co-founded by Daniel Silva Manzano, Alfredo Quijano-Rubio, and David Baker. The company is a leader in de novo protein design to create novel protein binders and biosensors for research use only (RUO) and in vitro diagnostic (IVD) applications. Monod Bio's proprietary AI platform enables the generation of novel proteins using in silico methods, including its NovoBody(TM) binders, to address unmet needs. Through its "Monod Inside" business model, Monod Bio partners with leading RUO and IVD organizations to bring next-generation products to market. For more information, visit http://monod.bio. About Gator Bio Gator Bio is a leading innovator in label-free biosensor technology, delivering high-performance analytical instruments for biomolecular interaction analysis. The company's biolayer interferometry (BLI) platform serves as a critical validation technology for AI-driven protein design, providing researchers with powerful tools for real-time, quantitative characterization of next-generation biologics including computationally designed proteins and antibodies. For more information, visit gatorbio.com Media Contact Sriram Kumaraswamy, Gator Bio, 1 855-208-0743, [email protected], www.gatorbio.com Nino Floro, Gator Bio, 1 6504205727, [email protected], www.gatorbio.com SOURCE Gator Bio

Yahoo Finance
May 13th, 2025
Gator Bio Unveils Novel New GeneSwift Reagents Revolutionizing Genome Titer and Genome Integrity Analysis

Gator Bio unveils novel new GeneSwift reagents revolutionizing genome titer and genome integrity analysis.

Educating America Today
Oct 16th, 2023
Gator Bio Launches Gator® Pilot and Gator® Pivot Biolayer Interferometry Systems for Biotherapeutics Discovery

Gator Bio launches Gator® Pilot and Gator® Pivot Biolayer Interferometry systems for biotherapeutics discovery.